Turalio

Product manufactured by Daiichi Sankyo Inc.

Application Nr Approved Date Route Status External Links
NDA211810 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Turalio Is Indicated For The Treatment Of Adult Patients With Symptomatic Tenosynovial Giant Cell Tumor (Tgct) Associated With Severe Morbidity Or Functional Limitations And Not Amenable To Improvement With Surgery. Turalio Is A Kinase Inhibitor Indicated For The Treatment Of Adult Patients With Symptomatic Tenosynovial Giant Cell Tumor (Tgct) Associated With Severe Morbidity Or Functional Limitations And Not Amenable To Improvement With Surgery. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Pexidartinib Hydrochloride

Comments